Polymeric Drugs and Drug Delivery Systems 2000
DOI: 10.1201/9781420010251.ch4
|View full text |Cite
|
Sign up to set email alerts
|

Design of Polymeric Systems for Targeted Administration of Peptide and Protein Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2002
2002
2006
2006

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Convenient procedures for the preparation of both malolactone monomers and the corresponding polymers have been developed over the last 20 years starting from commercially available natural products. [21][22][23] Following our continued interest in the production of bioerodible and biodegradable functional polymers for biomedical applications, [24][25][26][27][28][29][30][31][32] we synthesized and characterized a series of polyesters and copolyesters from new malolactonate monomers. Functionalization of the lateral chain of the malic residues was performed through esterification with readily available alcohols.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Convenient procedures for the preparation of both malolactone monomers and the corresponding polymers have been developed over the last 20 years starting from commercially available natural products. [21][22][23] Following our continued interest in the production of bioerodible and biodegradable functional polymers for biomedical applications, [24][25][26][27][28][29][30][31][32] we synthesized and characterized a series of polyesters and copolyesters from new malolactonate monomers. Functionalization of the lateral chain of the malic residues was performed through esterification with readily available alcohols.…”
Section: Introductionmentioning
confidence: 99%
“…Following our continued interest in the production of bioerodible and biodegradable functional polymers for biomedical applications, we synthesized and characterized a series of polyesters and copolyesters from new malolactonate monomers. Functionalization of the lateral chain of the malic residues was performed through esterification with readily available alcohols.…”
Section: Introductionmentioning
confidence: 99%
“…9 10 These receptors can recognize the galactose units on the oligosaccharide chains of glycoproteins or on chemically galactosylated drug carriers. 11 In the framework of a long-standing activity in the development of biocompatible polymers for biomedical and tissue engineering applications, [12][13][14][15][16][17][18][19][20][21] in a previous paper 18 we reported the formulations of nanoparticles loaded with -interferon ( -IFN), a proteic drug widely used in the treatment of hepatitis C. These carriers were prepared in order to achieve targeted and controlled delivery of -IFN to hepatocytes, the liver parenchymal cells that are affected by hepatitis C viral infection. To the best of our knowledge, no previous report on the targeted delivery of drugs to liver hepatocytes by biodegradable nanoparticles is present in the literature.…”
Section: Introductionmentioning
confidence: 99%
“…Following our continuing interest in the production of bioerodible and biodegradable functional polymers for biomedical application23–32 we prepared homopolymers and copolymers of new malolactonate monomers bearing side ester groups specifically designed for biological recognition, with the goal of obtaining highly effective polymeric scaffolds 33. The present paper reports a preliminary investigation of the monomer molecular geometry and its influence on the polymerization process.…”
Section: Introductionmentioning
confidence: 99%